TURPENTINE OINTMENT

INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT TURPENTINE OINTMENT (UNGUENTUM TEREBINTHINAE)

Composition:

Active substance: oleoresin turpentine;

1 g of ointment contains: 200 mg of oleoresin turpentine;

Excipients: soft white paraffin, emulsifier T-2, purified water.

Pharmaceutical form. Ointment.

Main physicochemical properties: ointment of white or whitish-yellowish color with the odor of turpentine. The ointment should be homogeneous in appearance.

Pharmacotherapeutic group.

Topical preparations used for joint and muscular pain.

ATC code M02A X10.

Pharmacological properties.

Turpentine ointment exerts distracting, anti-inflammatory, antiseptic, and analgesic effects. The distracting effect is associated with the ability to penetrate through the epidermis and cause reflex changes due to stimulation of skin receptors.

Clinical characteristics.

Indications.

In complex treatment of neuralgias, myositis, arthritis.

Contraindications.

Severe kidney and liver diseases, skin disorders of various etiology, increased sensitivity to the drug.

Special safety precautions.

Avoid contact of the ointment with mucous membranes and eyes! If the ointment accidentally gets into the eyes, they should be thoroughly rinsed with a large amount of running water.

Do not apply to damaged areas of the skin.

Interaction with other medicinal products and other forms of interaction.

Turpentine ointment is chemically incompatible with iodine solution.

Special precautions.

Use during pregnancy or breastfeeding.

It is unknown whether the drug penetrates into breast milk or crosses the placental barrier during pregnancy; therefore, the use of the drug during pregnancy and breastfeeding is contraindicated.

Ability to affect reaction rate when driving or operating machinery.

Caution should be exercised when driving or operating machinery due to the possible occurrence of generalized adverse reactions (see "Adverse reactions").

Method of Administration and Dosage

Apply turpentine ointment externally by rubbing it into the affected painful areas 2–3 times daily in adults. The duration of use is determined by the course of the disease and the therapeutic effect achieved.

The patient should consult a physician if symptoms of the disease do not subside during treatment or if adverse reactions not listed in the instructions for medical use occur.

Children.

There is no experience with the use of the drug in children; therefore, the ointment is not recommended for use in pediatric patients.

Overdose.

Possible development of increased sensitivity to the drug and intensification of adverse effects.

Side effects.

Immune system reactions: allergic reactions of a local nature may occur in case of hypersensitivity to the drug, including itching, swelling, redness of the skin, burning sensation, rash. In individual cases, generalized allergic reactions may occur, including urticaria, rapid heartbeat, decreased blood pressure, dizziness, seizures, loss of consciousness.

Shelf life. 3 years.

Storage conditions.

Store in the original packaging at a temperature not exceeding 25 °C.

Keep out of reach of children.

Packaging. 30 g in tubes.

Supply category. Over-the-counter.

Manufacturer: JSC "FITOPHARM".

Manufacturer's address and location of its business activity:

2 Sybirtseva Street, Bakhmut, Donetsk region, 84500, Ukraine.

Marketing Authorization Holder: JSC "FITOPHARM".

Address of the Marketing Authorization Holder:

12 Almatinska Street, Kyiv, 02092, Ukraine.